1-4 of 4
Hirohito Yamaguchi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer

Chun-Te Chen, Yi Du, Hirohito Yamaguchi, Jung-Mao Hsu, Hsu-Ping Kuo, Gabriel N. Hortobagyi, Mien-Chie Hung
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (10): 2212–2221.
https://doi.org/10.1158/1535-7163.MCT-12-0180
Published: 09 October 2012
View article titled, Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer
Open the PDF for Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase

Chun-Te Chen, Hirohito Yamaguchi, Hong-Jen Lee, Yi Du, Heng-Huan Lee, Weiya Xia, Wen-Hsuan Yu, Jennifer L. Hsu, Chia-Jui Yen, Hui-Lung Sun, Yan Wang, Edward T.H. Yeh, Gabriel N. Hortobagyi, Mien-Chie Hung
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (8): 1327–1336.
https://doi.org/10.1158/1535-7163.MCT-10-1117
Published: 08 August 2011
View article titled, Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
Open the PDF for Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase in another window
Includes: Supplementary data
Journal Articles

A novel hTERT promoter–driven E1A therapeutic for ovarian cancer

Xiaoming Xie, Jennifer L. Hsu, Min-Gew Choi, Weiya Xia, Hirohito Yamaguchi, Chun-Te Chen, Bon Q. Trinh, Zhen Lu, Naoto T. Ueno, Judith K. Wolf, Robert C. Bast, Jr., Mien-Chie Hung
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (8): 2375–2382.
https://doi.org/10.1158/1535-7163.MCT-09-0056
Published: 14 August 2009
View article titled, A novel hTERT promoter–driven E1A therapeutic for ovarian cancer
Open the PDF for A novel hTERT promoter–driven E1A therapeutic for ovarian cancer in another window
Includes: Supplementary data
Journal Articles

Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B

Lianne Fuino, Purva Bali, Sylvie Wittmann, Sreenivas Donapaty, Fei Guo, Hirohito Yamaguchi, Hong-Gang Wang, Peter Atadja, Kapil Bhalla
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (10): 971–984.
Published: 24 October 2003
View article titled, Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B
Open the PDF for Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B in another window